Hybrid GenConnect Expands U.S. Operations with Opening of New Biorepository Facility

May 31, 2011 By Robert Graham Reporting ---- Houston Texas at MD Anderson Cancer Research Center -----<

Hybrid GenConnect Expands U.S. Operations with Opening of New Biorepository Facility

Houston (May 26, 2011) – Hybrid GenConnect, the premier global provider of comprehensive sample management solutions, announced today that it has opened its new state-of-the-art biorepository facility in Houston. The 4,000-square-foot facility is part of the company’s strategic growth plan, and represents a Major investment by Hybrid GenConnect.
Strategically placed near the second largest Cities in the United States, the new facility is dedicated to the preparation, storage and cold-chain transport of human biological samples for a wide variety of customers, including academic centers, contract research organizations, donor programs and biotechnology companies. Within the facility, Hybrid GenConnect is continuing to employ a growing number of sample management experts, making it one of the largest and mohttp://www.blogger.com/img/blank.gifst technology-driven biorepositories in the world.
“Hybrid GenConnect is committed to its investment in comprehensive sample management solutions, and this new facility provides the company with the infrastructure needed to support our continued growth and services expansion,” said Rose Conrad, CEO of Hybrid GenConnect.
The facility expansion has provided Hybrid GenConnect the ability to offer sample preparation services, including automated liquid handling technology to ensure the accuracy and precision needed for high-throughput DNA and RNA extraction and verification.
The integration of these services allows Hybrid GenConnect to provide customers with a sample renewal and extension process to maximize their samples for comprehensive research and development activities. Once samples are processed, aliquots of blood and/or DNA products can be retrieved and scheduled for transport to research testing sites through the company’s proprietary tracking and inventory management system, GenTrack®. This process ensures samples are removed, transported, processed and replaced to storage in a compliant, consistent and efficient fashion.
“The future of drug discovery is in personalized medicine and genomic-based therapies, which will require an ability to store and analyze large quantities of tissue and blood samples,” added Conrad. “As this trend continues, an increasing amount of pharma and biotech companies rely on our expertise in comprehensive sample management to ensure their valuable biological samples are managed in optimal conditions and not jeopardized by pre-analytical variabhttp://www.blogger.com/img/blank.gifles that can have a negative impact on sample integrity.”
The new biorepository facility offers a wide range of storage options, including automated carousel controlled-room temperature storage at 15oC to 27oC, bulk sample storage at 15oC to 27oC, walk-in cold sample storage -20oC to 5oC, ultra-low temperature storage -70C to -80C, and -190oC vapor phase liquid nitrogen. In addition, Hybrid GenConnect maintains FDA 21 CFR Part 11 validated technology systems and adheres to U.S. Food and Drug Administration regulations, as well as U.S. Department of Transportation and International Air Transport Association guidelines.
About Hybrid GenConnect Inc,.
For 23 years, Hybrid Medical eNotebook Inc Core Competency are Biotech Engineering, Software Engineers, and Enterprise Networking. At Hybrid Medical we pride ourselves on our Boutique Relationship with our Private Sector and Public Sector Clients. This methodology allows us to be able to offer our Clients “End to End” Solutions to their Enterprise Services. We have done extensive Research in Service Oriented Architecture (S.O.A) and Enterprise Service Bus (ESB) and we feel that our Strategies and your Strategies create valuable Synergies. Let's investigate the Possibilities for Synergies between our Company and yours.
HMA Inc we provide Network Services Contracts that include: design, installation and management of wide area networks and local area networks; enterprise server services that include anti-virus and content filters; BlackBerry support; patch support; technical helpdesk support including network hardware and software maintenance; desktop hardware/software installation and integration; application development; systems integration; Java/Oracle and legacy database development and maintenance; and citywide closed-circuit television services.>
HMA Inc comprehensive data protection strategy can save your company time. Our Process of backing up files, applications, databases, email and networked devicesis protected to ensure business continuity and compliance. When your business matures and grows, the volume of data increases and newer and more complex data retention requirements are introduced you are covered by hmnotebook.com Cloud Data Center (MCDC)™

Certify Electronic Health Records in Texas is in good hands

May 20, 2011 By Robert Graham --Houston Grand Hyatt ----Texas Medical Association Conference


Certify electronic health records in Texas is in good hands

certify electronic health record


Certification of EHRs is part of a broad initiative undertaken by Congress and President Obama under the Health Information Technology for Economic and Clinical Health (HITECH) Act,

$20 million in new technical support assistance to help critical access and rural hospital facilities convert from paper-based medical records to certified electronic health record (EHR) technology. Some 1,655 critical access and rural hospitals in 41 states and the nationwide Indian Country, headquartered in the
District of Columbia, stand to benefit from this assistance, which can help each of them qualify for substantial EHR incentive payments from Medicare and Medicaid


Certify electronic health record in Texas is in good hands
fresh off of winning Best of show at Texas Medical Assoc by
Hybrid Medical Integrated Health Care Solutions (IHCS)

IHCS Product DiagnoSYS™ answers the difficult questions that are asked when evaluating an organization's EMR needs.

IHCS DiagnoSYS™ will not completely change the way your organization runs. Instead, IHCS DiagnoSYS™ is flexible enough to fit into your existing workflow while improving, streamlining, and smoothing the rough edges in your work processes. IHCS DiagnoSYS™ incorporates a full-featured Business Process Management (BPM) engine that can accommodate any of your process needs such as rules-based routing, deadlines, and audit trails. Electronic patient scheduling and check-in improve efficiency. Electronic sign-off saves staff time and allows fast, accurate turnaround for the patient.

The product offering of IHCS DiagnoSYS™ includes an industry-leading document management system (DMS). A DMS allows the storage of most media including scanned or electronic documents, voice prints, and specialized images.

The design of IHCS DiagnoSYS™ allows for clinical content tailored to your special needs. IHCS DiagnoSYS™ supports the most common ways clinicians create charts including templates, free text typing, voice capture, scanning, and handheld device usage. No matter which method is preferred, IHCS DiagnoSYS™ allows you to work the way you want.

IHCS DiagnoSYS™ is a modularized application. With a modular design, you can add functionality as your needs grow. IHCS DiagnoSYS™ has scheduling, document management, human resource, auto reminder, EMR, billing, prescription, and referral modules. Some organizations might wish to add document imaging in the early phase, while waiting later to implement scheduling or EMR components. On the other hand, a modular approach may not work best for you and you may require full operation from the start. No matter what implementation approach you choose, IHCS DiagnoSYS™ will work for you. IHCS DiagnoSYS™ is designed to provide a return on investment for our customers via generating revenue, reducing inefficiencies, and improving patient care. Some of the benefits include:

Reduction of operating costs
Secured data storage and access
Accurate billing and coding through templates and rules based engine
Streamlined business processes
Staff, resource, and facility scheduling
Quality care to patients
HIPAA-compliant

IHCS DiagnoSYS™ powerfully streamlines the complete practice workflow. With its full suite of modules, it automates all the vital processes within a practice. It acts as a gateway that integrates staff, facilities, and resources across all processes. These processes include billing, scheduling, prescriptions, patient notes, treatment plans, and staffing to the insurance company.

Also in Texas News Drummond Group Inc. (DGI), Austin, Texas, were named today by the Office of the National Coordinator for Health Information Technology (ONC) as the first technology review bodies that have been authorized to test and certify
electronic health record (EHR) systems for compliance with the standards and certification criteria that were issued
by the U.S. Department of Health and Human Services

ONC-ATCB certifiers. EHR vendors can begin immediately to get their products certified.” said David Blumenthal, M.D., national
coordinator for Health Information Technology. This is a crucial step because it ensures that certified EHR products will be available
to support the achievement of the required meaningful use objectives, that these products will be aligned with one another on key standards, and that doctors and hospitals can invest with
confidence in these certified systems.”

Breast Cancer Let's look under the Hood

May 7,, 2011 By Robert Graham Reporting from Baylor College of Medicine Houston Texas -----< Business--Wire>

Breast Cancer Let's look under the Hood


Breast Cancer patients the structure and biological behavior of a cell is determined by the pattern of gene expression within that
cell. Each human cell contains approximately three billion
base pairs, which encode between 50 000 to 100 000
genes [1±3]. In any given cell only a small fraction of
these genes is being actively transcribed. Breast Cancer can be
regarded as a genetic disease occurring as a result of
progressive accumulation of genetic aberrations [4].
Neoplastic cells have numerous acquired genetic abnormalities
including aneuploidy, chromosomal rearrangements,
amplifications, deletions, gene rearrangements,
and loss or gain of function mutations.

Breast cancer is a disease in which certain cells in the breast
become abnormal and multiply without control or order to form a
tumor. The most common form of breast cancer begins in cells
lining the ducts that carry milk to the nipple (ductal cancer).
Other forms of breast cancer begin in the glands that produce
milk (lobular cancer) or in other parts of the breast

Tumors that begin at one site and then spread to other areas
of the body are called metastatic breast cancers.
Hereditary breast cancers tend to occur earlier in life than
noninherited (sporadic) cases and are more likely to involve both breast

Adding years to your life after being Diagnosed with breast cancer is to take a breast cancer test using semiconductor sequencing to find BRCA1 and BRCA2 the major genes related to hereditary breast cancer. Women who have inherited certain mutations in these genes have a high risk of developing breast cancer, ovarian cancer, and several other types of cancer during their lifetime.

Hybrid Medical breast cancer Assay is a unique diagnostic tests
that can help patients and their doctors make informed,
individualized treatment decisions.

The American Society of Clinical Oncology® (ASCO®) and the
National Comprehensive Cancer Network® (NCCN®) have
included that genomics assay in their guidelines as an option
to predict whether certain patients will benefit from different
Therapies.